Bio-Techne Releases Second Quarter Fiscal 2019 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St futures muted as investors monitor US-Iran negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Bio-Techne (TECH) Tops Q2 EPS by 8c, Revenues Beat
February 5, 2019 6:34 AM ESTBio-Techne (NASDAQ: TECH) reported Q2 EPS of $1.06, $0.08 better than the analyst estimate of $0.98. Revenue for the quarter came in at $174.5 million versus the consensus estimate of $170.19 million.
Second quarter organic revenue increased by 11% (13% reported) to $174.5 million.GAAP EPS was $0.45 vs. $1.29 one year ago. Current Year GAAP EPS saw a one-time benefit for tax reform of $0.02 compared to a prior year GAAP EPS benefit of $0.94. Delivered adjusted earnings per share (EPS) of $1.06, an increase of 4% over the prior year. Excellent commercial execution in all major regions, especially China, with organic growth over... More